Form DEFA14A C4 Therapeutics, Inc.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )
_____________________
Filed by the Registrant x Filed by a Party other than the Registrant o
Check the appropriate box:
| o | Preliminary Proxy Statement | ||||
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a6(e)(2)) | ||||
o | Definitive Proxy Statement | ||||
| x | Definitive Additional Materials | ||||
o | Soliciting Material Pursuant to §240.14a12 | ||||
C4 THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check boxes that apply):
| x | No fee required. | ||||
o | Fee paid previously with preliminary materials. | ||||
o | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 011. | ||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Reef Origin, Xange.com and NOXXO Founders Launch Origin Assets to Finance Sustainable Real-World Assets
- Birth Injury Justice Center Says Hospital Delays in HIE Treatment May Be Medical Negligence
- RedCloud Signs Up to $120M India Joint Venture, to Deploy Its RAID Engine Into FMCG, Apparel and Footwear Categories
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
